Palisade Bio Inc
NASDAQ:PALI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Palisade Bio Inc
NASDAQ:PALI
|
US |
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
National Bankshares Inc
NASDAQ:NKSH
|
US |
|
Investigator Resources Ltd
ASX:IVR
|
AU |
|
Dampskibsselskabet Norden A/S
CSE:DNORD
|
DK |
|
CIR SpA - Compagnie Industriali Riunite
MIL:CIR
|
IT |
|
K
|
Kulicke and Soffa Industries Inc
XMUN:KU1
|
SG |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
AU Small Finance Bank Ltd
BSE:540611
|
IN |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
|
CarGurus Inc
NASDAQ:CARG
|
US |
|
Galapagos NV
OTC:GLPGF
|
BE |
|
Naturgy Energy Group SA
OTC:GASNY
|
ES |
|
Vitesco Technologies Group AG
OTC:VTSCF
|
DE |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
National Australia Bank Ltd
ASX:NAB
|
AU |
|
V
|
Very Good Food Company Inc
XTSX:VERY
|
CA |
|
Coca-Cola Co
NYSE:KO
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
Wilmar International Ltd
SGX:F34
|
SG |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
C
|
China Literature Ltd
OTC:CHLLF
|
CN |
Wall St Price Targets
PALI Price Targets Summary
Palisade Bio Inc
According to Wall Street analysts, the average 1-year price target for
PALI is 10.2 USD with a low forecast of 5.05 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PALI's stock price target?
Price Target
10.2
USD
According to Wall Street analysts, the average 1-year price target for
PALI is 10.2 USD with a low forecast of 5.05 USD and a high forecast of 26.25 USD.